-
Correction: The UPDATE trial (UVB Phototherapy in Dermatology for ATopic Eczema): study protocol for a randomized controlled trial of narrowband UVB with optimal topical therapy versus optimal topical therapy in patients with atopic eczema (Trials, (2024), 25, 1, (482), 10.1186/s13063-024-08334-z)
Knöps, E., Spuls, P., Duijnhoven, R., Dijkgraaf, M., van Barreveld, M., Arents, B., van Enst, A., Garritsen, F., Merkus, M., Middelkamp-Hup, M. A., Musters, A., Bosma, A., Hyseni, A., Dijkstra, J., Hijnen, D. J. & Gerbens, L., Dec 2025, In: Trials. 26, 1, 55.Research output: Contribution to journal › Comment/Letter to the editor* › Academic
-
The UPDATE trial (UVBPhototherapy in Dermatology for ATopic Eczema): study protocol for a randomized controlled trial of narrowband UVB with optimal topical therapy versus optimal topical therapy in patients with atopic eczema
Knöps, E., Spuls, P., Duijnhoven, R., Dijkgraaf, M., van Barreveld, M., Arents, B., van Enst, A., Garritsen, F., Merkus, M., Middelkamp-Hup, P., Musters, A., Bosma, A., Hyseni, A., Dijkstra, J., Hijnen, D. J. & Gerbens, L., 1 Dec 2024, In: Trials. 25, 1, 482.Research output: Contribution to journal › Article* › Academic › peer-review
-
Clinical and humoral response after SARS-CoV-2 breakthrough infection in patients receiving immunosuppressant therapy
the T2B! immunity against SARS-CoV-2 study group, Schreurs, C. R. G., van der Pol, W. L., Goedee, H. S. & T2B! immunity against SARS-CoV-2 study group, Sept 2024, In: Journal of allergy and clinical immunology. 154, 3, p. 754-766.e7Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
